These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 287817)
1. Control of drug substitution is the real issue. Stetler CJ J Med Soc N J; 1979 Jun; 76(6):458-9. PubMed ID: 287817 [No Abstract] [Full Text] [Related]
2. More on genetic substitution. Luger S; Culkin TT J Med Soc N J; 1979 Jun; 76(6):477. PubMed ID: 287818 [No Abstract] [Full Text] [Related]
3. New York's generic drug substitution law. Kamen A N Y State Dent J; 1980 Nov; 46(9):599-604. PubMed ID: 6935574 [No Abstract] [Full Text] [Related]
4. The real costs of generic substitution. Ballin JC N Y State J Med; 1988 Mar; 88(3):121-2. PubMed ID: 3357610 [No Abstract] [Full Text] [Related]
5. The brand name versus generic controversy: Is there a segment of the pharmaceutical industry that produces drugs of higher quality? Marsh DA; Hoar ME Contemp Pharm Pract; 1982; 5(2):130-5. PubMed ID: 10317245 [TBL] [Abstract][Full Text] [Related]
6. Brands or generics: the dilemma of pharmaceutical marketing in a developing country. Quraeshi ZA; Luqmani M; Malhotra N J Health Care Mark; 1983; 3(4):27-37. PubMed ID: 10264767 [TBL] [Abstract][Full Text] [Related]
7. Substitution--the New York State experience. DeNuzzo RV Med Mark Media; 1981 Jan; 16(1):25-9. PubMed ID: 10249801 [No Abstract] [Full Text] [Related]
8. Opinions of pharmacy, medicine, and pharmaceutical industry leaders about hypothetical therapeutic-interchange legislation. Segal R; Grines LL; Pathak DS Am J Hosp Pharm; 1988 Mar; 45(3):570-7. PubMed ID: 3369459 [TBL] [Abstract][Full Text] [Related]
9. Attorney General limits generic drug substitution. Hall SL Mich Med; 1975 Mar; 74(9):148-9. PubMed ID: 1124017 [No Abstract] [Full Text] [Related]
10. Generic substitution laws--physicians' liability. Trout ME J Leg Med (N Y); 1977 Jul; 5(7):14-6. PubMed ID: 301915 [No Abstract] [Full Text] [Related]
11. Generic prescribing and the drug industry. Br Med J (Clin Res Ed); 1982 Mar; 284(6320):919. PubMed ID: 6802347 [No Abstract] [Full Text] [Related]
12. Forces and direction of drug product selection legislation. Stewart JE Med Mark Media; 1979 Jun; 14(6):34-6, 38-9. PubMed ID: 10242281 [No Abstract] [Full Text] [Related]
14. A defense of the learned intermediary doctrine. Goetz RB; Growdon KR Food Drug Law J; 2008; 63(2):421-38. PubMed ID: 18561470 [No Abstract] [Full Text] [Related]
15. Anti-substitution law repeal--pro and con: the case against repeal. Perloff MM Am J Pharm Sci Support Public Health; 1971; 143(1):15-23. PubMed ID: 5162747 [No Abstract] [Full Text] [Related]
16. Drug product selection legislation: a comparative analysis. Wetherbee H; Sharpe TR Am J Pharm Sci Support Public Health; 1978; 150(6):171-6. PubMed ID: 576098 [No Abstract] [Full Text] [Related]